Clinical trial

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

NCT02654665

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BEHAVIORAL · Unmapped registry intervention Lifestyle modification Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Liraglutide Normalized identity: liraglutideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-03-01

PhasePHASE3

Conditions

Non-alcoholic Fatty Liver Disease (NAFLD)unresolved

Weight Lossunresolved

Non-alcoholic Steatohepatitis (NASH)unresolved

Interventions

Lifestyle modificationBEHAVIORAL

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Changi General Hospitallead sponsor

Mapped research locations

SingaporeSingapore1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02654665 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.